日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

USP51/GRP78/ABCB1 axis confers chemoresistance through decreasing doxorubicin accumulation in triple-negative breast cancer cells.

USP51/GRP78/ABCB1 轴通过降低三阴性乳腺癌细胞中阿霉素的积累来赋予化疗耐药性

期刊:Acta Pharmaceutica Sinica B
影响因子:14.6
doi:10.1016/j.apsb.2025.03.004
Ou Yang, Zhang Kun, Shuai Qiuying, Wang Chenyang, Hu Huayu, Cao Lixia, Qi Chunchun, Guo Min, Li Zhaoxian, Shi Jie, Liu Yuxin, Zuo Siyu, Chen Xiao, Wang Yanjing, Feng Mengdan, Wang Hang, Sun Peiqing, Shi Yi, Yang Guang, Yang Shuang
细胞生物学
乳腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Breast cancer cell-derived adrenomedullin confers cancer-associated adipose remodeling through the cAMP/Creb1/Zeb1 axis.

乳腺癌细胞衍生的肾上腺髓质素通过 cAMP/Creb1/Zeb1 轴赋予癌症相关的脂肪重塑。

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-025-03219-7
Chen Xiao, Cao Lixia, Feng Mengdan, Shuai Qiuying, Guo Min, Li Zhaoxian, Qi Chunchun, Shi Jie, Liu Yuxin, Zuo Siyu, Yu Tianwen, Hu Huayu, Wang Yanjing, Xue Yao, Sun Peiqing, Shi Yi, Wang Hang, Liu Lei, Yang Shuang
肿瘤
肿瘤免疫
乳腺癌
GPCR/Calcium/cAMP
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Correction: Chidamide combined with doxorubicin induced p53-driven cell cycle arrest and cell apoptosis reverse multidrug resistance of breast cancer

更正：西达米德联合阿霉素诱导的p53驱动的细胞周期阻滞和细胞凋亡逆转了乳腺癌的多药耐药性

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1722174
Cao, Lixia; Zhao, Shaorong; Yang, Qianxi; Shi, Zhendong; Liu, Jingjing; Pan, Teng; Zhou, Dongdong; Zhang, Jin
肿瘤
凋亡
表观遗传
肿瘤免疫
乳腺癌
细胞生物学
发表日期：2025
文献求助 收藏

A case report of tumor-associated liver injury alleviated with antineoplastic drug

一例肿瘤相关性肝损伤经抗肿瘤药物缓解的病例报告

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1644790
Yang, ZiRu; Cao, Lixia; Kuai, Wentao; Yao, Shengjuan; Li, Shuang; Xu, Liang
肝损伤
肿瘤
毒理研究
肿瘤免疫
发表日期：2025
文献求助 收藏

Erratum: Deciphering the performance of polo-like kinase 1 in triple-negative breast cancer progression according to the centromere protein U-phosphorylation pathway

勘误：根据着丝粒蛋白U磷酸化途径解读polo样激酶1在三阴性乳腺癌进展中的作用

期刊:American Journal of Cancer Research
影响因子:2.9
doi:10.62347/CNOZ7246
Zhao, Shaorong; Geng, Yannan; Cao, Lixia; Yang, Qianxi; Pan, Teng; Zhou, Dongdong; Liu, Jingjing; Shi, Zhendong; Zhang, Jin
肿瘤
肿瘤免疫
信号转导
乳腺癌
磷酸化
发表日期：2025
文献求助 收藏

Preclinical studies of BB-1701, a HER2-targeting eribulin-containing ADC with potent bystander effect and ICD activity.

BB-1701 是一种靶向 HER2 的含艾立布林的抗体药物偶联物 (ADC)，具有强大的旁观者效应和 ICD 活性，其临床前研究

期刊:Antibody Therapeutics
影响因子:4.5
doi:10.1093/abt/tbae019
Wang Yang, Xia Bing, Cao Lixia, Yang Jianfeng, Feng Cui, Jiang Fangdun, Li Chen, Gu Lixia, Yang Yifan, Tian Jing, Cheng Xin, Furuuchi Keiji, Fulmer James, Verdi Arielle, Rybinski Katherine, Soto Allis, Albone Earl, Uenaka Toshimitsu, Gong Likun, Liu Tingting, Qin Qiuping, Wei Ziping, Zhou Yuhong
其它
药物研究
发表日期：2024
文献求助 收藏

Targeted delivery of miR-34a-5p by phenylborate-coupled polyethylenimide nanocarriers for anti-KSHV treatment

苯硼酸偶联聚乙烯酰亚胺纳米载体靶向递送 miR-34a-5p 用于抗 KSHV 治疗

期刊:Frontiers in Bioengineering and Biotechnology
影响因子:4.3
doi:10.3389/fbioe.2023.1343956
Fangling Li #, Dongdong Cao #, Lixia Yao #, Wenyi Gu, Zhiyong Liu, Dongmei Li, Lin Cui
发表日期：2024
文献求助 收藏

Peripheral Blood Leukocyte Detection Based on an Improved Detection Transformer Algorithm

基于改进检测转换器算法的外周血白细胞检测

期刊:Sensors
影响因子:3.5
doi:10.3390/s23167226
Li, Mingjing; Fang, Shu; Wang, Xiaoli; Chen, Shuang; Cao, Lixia; Han, Jinye; Yun, Haijiao
细胞生物学
发表日期：2023
文献求助 收藏

Research on automatic matching of online mathematics courses and design of teaching activities based on multiobjective optimization algorithm

基于多目标优化算法的在线数学课程自动匹配及教学活动设计研究

期刊:PeerJ Computer Science
影响因子:2.5
doi:10.7717/peerj-cs.1501
Li, Jiafeng; Cao, Lixia; Zhang, Guoliang
发表日期：2023
文献求助 收藏

Socioeconomic and clinical factors affecting the proportion of breast conserving surgery in Chinese women with breast cancer

影响中国乳腺癌患者保乳手术比例的社会经济和临床因素

期刊:Gland Surgery
影响因子:1.6
doi:10.21037/gs-22-25
Liu, Jingjing; Zhou, Dongdong; Pan, Teng; Cao, Lixia; Yang, Qianxi; Zhang, Jin
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏